The Fifth Annual Symposium of the Midwest Aging Consortium
- PMID: 39704343
- PMCID: PMC11772560
- DOI: 10.1093/gerona/glae296
The Fifth Annual Symposium of the Midwest Aging Consortium
Abstract
As the healthcare burden caused by an increasingly aging population rapidly rises, a pressing need exists for innovative geroscience research that can elucidate aging mechanisms and precipitate the development of therapeutic interventions to support healthy aging. The Fifth Annual Midwest Aging Consortium Aging Research symposium, held from April 28 to 30, 2024, was hosted by The Ohio State University in Columbus, Ohio, and featured presentations from investigators across the Midwestern United States. This report summarizes the research presented at the symposium, whose topics included cellular senescence and the aging brain, metabolism and metabolic interventions, nutrition, redox mechanisms and biomarkers, and stress mechanisms. Abstract presentations and short talks highlighted early-stage and young investigators, whereas 2 keynote presentations anchored the symposium. Overall, this symposium showed the robustness of aging research in the Midwest and underscored the advantages of a collaborative approach to geroscience research.
Keywords: Biomarkers; Cellular senescence; Geroscience; Metabolism; Nutrition; Stress.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Gerontological Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
D.W.L. has received funding from, and is a scientific advisory board member of, Aeovian Pharmaceuticals, which seeks to develop novel, selective mTOR inhibitors for the treatment of various diseases. B.D.S. holds US patent 10,905,706, “Compositions and methods to accelerate resolution of acute lung inflammation,” and serves on the scientific advisory board of Zoe Biosciences, in which he holds stock options. L.Z. is a co-founder and shareholder of SingulOmics Corp. The other authors declare no conflict.
References
-
- Cuervo AM, Dice JF.. Age-related decline in chaperone-mediated autophagy. J Biol Chem. 2000;275:31505–31513. https://doi.org/10.1074/jbc.M002102200 - DOI - PubMed
-
- Cuervo AM, Dice JF.. A receptor for the selective uptake and degradation of proteins by lysosomes. Science. 1996;273:501–503. https://doi.org/10.1126/science.273.5274.501 - DOI - PubMed
-
- Kaushik S, Cuervo AM.. The coming of age of chaperone-mediated autophagy. Nat Rev Mol Cell Biol. 2018;19:365–381. https://doi.org/10.1038/s41580-018-0001-6 - DOI - PMC - PubMed
-
- Juste YR, Kaushik S, Bourdenx M, et al.Reciprocal regulation of chaperone-mediated autophagy and the circadian clock. Nat Cell Biol. 2021;23:1255–1270. https://doi.org/10.1038/s41556-021-00800-z - DOI - PMC - PubMed
-
- Bourdenx M, Martin-Segura A, Scrivo A, et al.Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome. Cell. 2021;184:2696–2714.e25. https://doi.org/10.1016/j.cell.2021.03.048 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- Cleveland State University startup funds
- R01 DK12744/GF/NIH HHS/United States
- DP2CA271361/Office of the NIH Director
- R01 DK133859/DK/NIDDK NIH HHS/United States
- AG056771/NIH/NIA
- Prevent Cancer Foundation
- P50 CA180908/CA/NCI NIH HHS/United States
- UL1 TR001070/TR/NCATS NIH HHS/United States
- R01 AG059711/AG/NIA NIH HHS/United States
- Glen Foundation for Medical Research
- R01 HL153122/HL/NHLBI NIH HHS/United States
- R01 AG060542/AG/NIA NIH HHS/United States
- Boehringer Ingelheim
- 24POST1196199/American Heart Association Postdoctoral 1099 Fellowship
- U19 AI181102/AI/NIAID NIH HHS/United States
- Hevolution/AFAR
- OSU the Infectious Disease Institute
- R13AG087673/NH/NIH HHS/United States
- AHA904048/American Heart Association
- AFAR/Hevolution New Investigator Award
- R13 AG087673/AG/NIA NIH HHS/United States
- I01 CX001932/CX/CSRD VA/United States
- R01 HL149883/GF/NIH HHS/United States
- R01 AG059711/CA/NCI NIH HHS/United States
- K99 AR081898/AR/NIAMS NIH HHS/United States
- P01AG051449/GF/NIH HHS/United States
- Hevolution Foundation Partnership
- I01 BX001324/BX/BLRD VA/United States
- VA/VA/United States
- R03 AG064374/AG/NIA NIH HHS/United States
- S. Parmar Travel Award
- DP2 EB028110/EB/NIBIB NIH HHS/United States
- R01 AG063543-02S1/GF/NIH HHS/United States
- P01 AG049665/AG/NIA NIH HHS/United States
- R01 AG084156/AG/NIA NIH HHS/United States
- DP2 CA271361/CA/NCI NIH HHS/United States
- R03 AG064374/GF/NIH HHS/United States
- R01 AG060542/GF/NIH HHS/United States
- IK6 BX006192/BX/BLRD VA/United States
- V Foundation
- U19 AI135964/AI/NIAID NIH HHS/United States
- College of Public Health and James Comprehensive Cancer Center
- The Ohio State University Comprehensive Cancer Center
- Hevolution Award AGE-003
- F32 AG077916/AG/NIA NIH HHS/United States
- K99/R00 AG058798/GF/NIH HHS/United States
- Pew Charitable Trusts
- AG 060907/National Institutes on Aging
- P01 AG062413/AG/NIA NIH HHS/United States
- R01 NS132760/NS/NINDS NIH HHS/United States
- P01 HL154998/HL/NHLBI NIH HHS/United States
- UG3 CA275669/CA/NCI NIH HHS/United States
- R01 HL168630/GF/NIH HHS/United States
- IK6BX006192/Medical Discovery Team on the Biology of Aging
- P50CA180908/Food and Drug Administration Center for Tobacco Products
- Lisa Dean Moseley Foundation
- RF1 AG056771/AG/NIA NIH HHS/United States
- 1DP2EB028110-01/GF/NIH HHS/United States
- American Federation for Aging Research
- OSU Division of Pulmonary, Critical Care, and Sleep Medicine
- R00 AG058800/GF/NIH HHS/United States
- DK125859/DK/NIDDK NIH HHS/United States
- U19 AG056278/AG/NIA NIH HHS/United States
- R01 DK125859/DK/NIDDK NIH HHS/United States
- R01 HL147290/HL/NHLBI NIH HHS/United States
- P30 CA016058/CA/NCI NIH HHS/United States
- R37 AG021904/GF/NIH HHS/United States
- R00 AR081898/AR/NIAMS NIH HHS/United States
- R01 AG021961/AG/NIA NIH HHS/United States
- P01 AG051449/AG/NIA NIH HHS/United States
- OSU Davis Heart Lung Research Institute
- K99 AG084921/AG/NIA NIH HHS/United States
- I01BX001324/Department of Veterans Affairs Merit Review
- R01 HL147575/HL/NHLBI NIH HHS/United States
- San Antonio Nathan Shock Center Pilot Grant
- Glenn Foundation for Medical Research
- R01 DK098408/DK/NIDDK NIH HHS/United States
- Glenn Foundation for Medical Research/AFAR
- HF-GRO-23-1199062-14/Hevolution Award
- R01 HL149883/HL/NHLBI NIH HHS/United States
- Pelotonia Intramural Research Funds
- T32 AG000213/GF/NIH HHS/United States
- The Ohio State University
- McKnight Land-Grant Professorship
- R35 GM140881/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
